[CTXR] YoY Quarter Result on 30-Jun-2022 [#Q3]

Stock
[CTXR] Citius Pharmaceuticals, Inc.
Announcement Date
11-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q3]
Profit Trend
QoQ- -17.00%
YoY- -51.29%
Quarter Report
CTXR's Result
CTXR's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -10,429 -8,335 -8,864 -5,824 -4,680 -4,406 -2,022 31.41%
Tax 144 144 -53 63 13 25 0 -
NP -10,573 -8,479 -8,811 -5,824 -4,680 -4,406 -2,022 31.71%
Tax Rate - - - - - - - -
Total Cost 10,573 8,479 8,811 5,824 4,680 4,406 2,022 31.71%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -0.06 -0.06 -0.06 -0.04 -0.11 -0.20 -0.19 -17.46%
EPS Diluted -0.06 -0.06 -0.06 -0.04 -0.11 -0.20 -0.19 -17.46%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.